# ERDERA Clinical Trial Call 2026 (pre-announcement)

**Funder:** ERDERA
**Deadline:** 29 October 2026 (Two-stage call — pre-proposal deadline shown; full-proposal deadline 2027-09-30)
**Consortium:** Required
**Application:** Pre-proposal submission: 2026-10-29; Full-proposal submission: 2027-09-30
**Official call:** https://www.era-learn.eu/network-information/networks/rare-diseases/erdera-clinical-trial-call-2026-pre-announcement
**Last updated:** 25 Sept 2026

## Eligibility & scope

ERDERA Clinical Trial Call 2026 (pre-announcement), listed under ERDERA on the ERA-LEARN call calendar. See the call guidance for funding, eligibility and consortium requirements.

## Summary

The ERDERA Clinical Trial Call 2026 funds consortium-based clinical trials, pre-announced under the European Rare Disease Research Alliance (ERDERA). The call runs as a two-stage process, with a pre-proposal submission in October 2026 followed by a full-proposal stage in September 2027, and is open to research teams working on rare disease clinical trials that can form the required consortium.

## Who should apply

- Research teams planning clinical trials in rare diseases
- Consortia able to meet ERDERA's required partnership structure
- Applicants prepared for a two-stage submission process spanning almost a year
- Institutions engaged in rare disease research networks under ERA-LEARN

## Key dates

- Pre-proposal deadline: 29 October 2026
- Full-proposal deadline: 30 September 2027
- Two-stage application process (pre-proposal, then full proposal)

## Tips for applicants

- This is a pre-announcement, check ERA-LEARN and ERDERA channels for the full call text before assembling a consortium.
- With nearly a year between pre-proposal and full-proposal stages, use the gap to firm up consortium roles and trial design rather than rushing the initial submission.
- Confirm exact funding amounts and eligibility rules in the official call guidance, since the pre-announcement does not fix these details.

## Frequently asked questions

### When is the ERDERA Clinical Trial Call 2026 deadline?

The pre-proposal deadline is 29 October 2026, with a full-proposal deadline of 30 September 2027 for those invited to the second stage.

### Is the ERDERA Clinical Trial Call 2026 a two-stage call?

Yes, it requires a pre-proposal submission followed by a full-proposal submission almost a year later.

### Do I need a consortium to apply to the ERDERA Clinical Trial Call 2026?

Yes, a consortium is required, though the call guidance should be checked for specific composition rules.

### What does the ERDERA Clinical Trial Call 2026 fund?

It funds clinical trials under the European Rare Disease Research Alliance (ERDERA), as listed on the ERA-LEARN call calendar.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/erdera-clinical-trial-call-2026-pre-announcement) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=erdera-clinical-trial-call-2026-pre-announcement).